GENNEX LABORATORIES
Quarterly Results Analysis [Dec2023]
GENNEX LABORATORIES Quarterly Results
Consolidated | Dec2023 UnAudited |
Sep2023 UnAudited |
Jun2023 UnAudited |
Dec2022 UnAudited |
Sep2022 UnAudited |
Jun2022 UnAudited |
Dec2021 UnAudited |
Sep2021 UnAudited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹21 Cr | ₹18 Cr | ₹16 Cr | ₹15 Cr | ₹20 Cr | ₹14 Cr | ₹17 Cr | ₹14 Cr |
Expenses | ₹17 Cr | ₹12 Cr | ₹11 Cr | ₹13 Cr | ₹18 Cr | ₹13 Cr | ₹15 Cr | ₹12 Cr |
Operating Income | ₹5 Cr | ₹6 Cr | ₹5 Cr | ₹2 Cr | ₹2 Cr | ₹1 Cr | ₹1 Cr | ₹2 Cr |
Other Income | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹1 Cr | ₹0 Cr | ₹0 Cr |
Interest | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
Depreciation | ₹0 Cr | ₹1 Cr | ₹1 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
Profit Before Tax | ₹4 Cr | ₹4 Cr | ₹4 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹2 Cr |
Profit After Tax | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr |
EPS | ₹0.16 | ₹0.17 | ₹0.16 | ₹0.07 | ₹0.08 | ₹0.06 | ₹0.06 | ₹0.08 |
Industry Peers & Returns | 1W | 1M | 1Y |
GENNEX LABORATORIES | -1.4% | -6.5% | 178.6% |
SUN PHARMACEUTICAL INDUSTRIES | -2.3% | -6.5% | 55.3% |
CIPLA | 4.1% | -4.8% | 55.6% |
DR REDDYS LABORATORIES | 4% | 0.8% | 29.4% |
ZYDUS LIFESCIENCES | -1.2% | -5.2% | 83.9% |
DIVIS LABORATORIES | 7.8% | 17.4% | 20.3% |
MANKIND PHARMA | 1.3% | 7% | NA |
TORRENT PHARMACEUTICALS | 3.9% | 5.1% | 66.1% |
LUPIN | 0.6% | 0.5% | 127.2% |
GENNEX LABORATORIES Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | 17.71 % |
Y-o-Y | 9.04 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Dec2023 | ₹21 Cr | 17.71 | |
Sep2023 | ₹18 Cr | 10.24 | |
Jun2023 | ₹16 Cr | 12.75 | |
Dec2022 | ₹15 Cr | -25.48 | |
Sep2022 | ₹20 Cr | 40.80 | |
Jun2022 | ₹14 Cr | -16.46 | |
Dec2021 | ₹17 Cr | 16.73 | |
Sep2021 | ₹14 Cr | - |
GENNEX LABORATORIES Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | -16.85 % |
Y-o-Y | 158.93 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Dec2023 | ₹5 Cr | -16.85 | |
Sep2023 | ₹6 Cr | 13.90 | |
Jun2023 | ₹5 Cr | 178.35 | |
Dec2022 | ₹2 Cr | -1.78 | |
Sep2022 | ₹2 Cr | 111.77 | |
Jun2022 | ₹1 Cr | -34.41 | |
Dec2021 | ₹1 Cr | -31.38 | |
Sep2021 | ₹2 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | -29.36 % |
Y-o-Y | 137.50 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Dec2023 | 22.42% | -29.36 | |
Sep2023 | 31.74% | 3.29 | |
Jun2023 | 30.73% | 146.83 | |
Dec2022 | 12.45% | 31.89 | |
Sep2022 | 9.44% | 50.32 | |
Jun2022 | 6.28% | -21.50 | |
Dec2021 | 8% | -41.18 | |
Sep2021 | 13.6% | - |
GENNEX LABORATORIES Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | -9.82 % |
Y-o-Y | 163.99 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Dec2023 | ₹3 Cr | -9.82 | |
Sep2023 | ₹3 Cr | 7.58 | |
Jun2023 | ₹3 Cr | 162.82 | |
Dec2022 | ₹1 Cr | 3.53 | |
Sep2022 | ₹1 Cr | 39.04 | |
Jun2022 | ₹1 Cr | -4.56 | |
Dec2021 | ₹1 Cr | -28.60 | |
Sep2021 | ₹1 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | -23.37 % |
Y-o-Y | 141.95 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Dec2023 | 12.92 % | -23.37 | |
Sep2023 | 16.86 % | -2.43 | |
Jun2023 | 17.28 % | 133.20 | |
Dec2022 | 7.41 % | 38.76 | |
Sep2022 | 5.34 % | -1.11 | |
Jun2022 | 5.4 % | 14.16 | |
Dec2021 | 4.73 % | -38.81 | |
Sep2021 | 7.73 % | - |
GENNEX LABORATORIES Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | -5.88 % |
Y-o-Y | 100.00 % |
Quarters | EPS | % Change | |
---|---|---|---|
Dec2023 | ₹0.16 | -5.88 | |
Sep2023 | ₹0.17 | 6.25 | |
Jun2023 | ₹0.16 | 128.57 | |
Dec2022 | ₹0.07 | -12.50 | |
Sep2022 | ₹0.08 | 33.33 | |
Jun2022 | ₹0.06 | 0.00 | |
Dec2021 | ₹0.06 | -25.00 | |
Sep2021 | ₹0.08 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs MANKIND PHARMA LTD